Giovanni Camussi Selected Research

Giovanni Camussi Research Topics

Disease

44	Neoplasms (Cancer) 01/2023 - 06/2003
17	Inflammation (Inflammations) 01/2022 - 08/2002
13	Proteinuria 01/2020 - 10/2002
11	Reperfusion Injury 01/2023 - 08/2003
9	Hypoxia (Hypoxemia) 11/2019 - 01/2012
9	Acute Kidney Injury (Acute Renal Failure) 05/2019 - 01/2008
8	Fibrosis (Cirrhosis) 01/2022 - 11/2016
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 04/2003
7	Ischemia 01/2022 - 01/2011
7	Necrosis 01/2020 - 10/2002
6	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2009
6	Renal Cell Carcinoma (Grawitz Tumor) 11/2018 - 08/2002
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2014 - 04/2003
5	Sepsis (Septicemia) 09/2022 - 10/2002
5	Glomerulonephritis 01/2021 - 06/2005
5	Infections 03/2010 - 10/2002
4	Chronic Renal Insufficiency 01/2022 - 01/2019
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017 - 04/2003
4	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2010 - 07/2002
4	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2009 - 09/2006
3	Disease Progression 01/2023 - 01/2007
3	Burns 12/2022 - 01/2008
3	Carcinoma (Carcinomatosis) 08/2022 - 09/2006
3	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2020 - 02/2003
3	Rhabdomyolysis 11/2016 - 05/2013
3	Kidney Neoplasms (Kidney Cancer) 12/2015 - 12/2011
2	Melanoma (Melanoma, Malignant) 01/2023 - 09/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2021
2	Triple Negative Breast Neoplasms 08/2022 - 10/2020
2	Acute Coronary Syndrome 09/2021 - 01/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 09/2012
2	Hyperglycemia 01/2019 - 08/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2016
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2017 - 07/2005
2	Pathologic Processes 11/2016 - 01/2016
2	Carcinogenesis 01/2014 - 02/2004

Drug/Important Bio-Agent (IBA)

18	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2011
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2002
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2014
10	nephrinIBA 09/2009 - 04/2003
8	CytokinesIBA 01/2022 - 07/2003
8	matrigelIBA 01/2019 - 09/2003
7	Messenger RNA (mRNA)IBA 11/2023 - 02/2006
6	Platelet Activating FactorIBA 10/2007 - 08/2002
4	Therapeutic UsesIBA 09/2022 - 01/2019
4	CateninsIBA 10/2021 - 05/2005
4	Complement System Proteins (Complement)IBA 01/2021 - 06/2003
4	Interleukin-3 (Interleukin 3)IBA 10/2020 - 07/2002
4	Urea (Carbamide)FDA LinkGeneric 01/2020 - 01/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2005
4	EnzymesIBA 01/2018 - 09/2003
4	AntigensIBA 08/2014 - 02/2006
4	Phospholipids (Phosphatides)FDA LinkGeneric 02/2006 - 08/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022 - 01/2011
3	salicylhydroxamic acid (SHAM)IBA 09/2021 - 05/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2003
3	erucylphosphocholineIBA 01/2021 - 10/2004
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
3	CreatinineIBA 01/2020 - 01/2008
3	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2018
3	SteroidsIBA 01/2017 - 07/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2004
3	Glycerol (Glycerine)FDA LinkGeneric 11/2016 - 10/2010
3	Cadherins (E-Cadherin)IBA 03/2016 - 05/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015 - 01/2009
3	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2010 - 04/2006
3	Angiotensin IIIBA 01/2009 - 04/2003
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2008 - 07/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 04/2006
2	Phenobarbital (Luminal)FDA Link 08/2022 - 12/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2021 - 03/2004
2	AutoantibodiesIBA 10/2020 - 06/2003
2	aristolochic acid I (aristolochic acid)IBA 01/2020 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2019 - 05/2015
2	ImmunosorbentsIBA 01/2018 - 08/2014
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 08/2014
2	CaspasesIBA 01/2018 - 01/2015
2	Erythropoietin FDA Link 11/2016 - 07/2013
2	LipopolysaccharidesIBA 04/2016 - 01/2013
2	Tumor Biomarkers (Tumor Markers)IBA 03/2016 - 01/2014
2	NestinIBA 03/2016 - 10/2008
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 02/2004
2	Nucleic AcidsIBA 01/2016 - 01/2016
2	Conditioned Culture MediaIBA 04/2015 - 10/2009
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2014 - 08/2010
2	Caspase 3 (Caspase-3)IBA 08/2014 - 10/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 12/2006
2	Interleukin-15 (Interleukin 15)IBA 02/2013 - 12/2011

Therapy/Procedure

19	Therapeutics 10/2020 - 01/2006
6	Transplantation 01/2023 - 10/2008
3	Intravenous Injections 10/2020 - 10/2010
3	Liver Transplantation 01/2020 - 01/2013
3	Immunotherapy 01/2016 - 12/2011
2	Percutaneous Coronary Intervention 09/2021 - 01/2021
2	Subcutaneous Injections 01/2020 - 03/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 11/2016
2	Kidney Transplantation 01/2015 - 02/2013
2	Drug Therapy (Chemotherapy) 01/2015 - 03/2010